S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: Wall Street higher, but likely not enough to this turn losing week into a winner
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: Wall Street higher, but likely not enough to this turn losing week into a winner
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: Wall Street higher, but likely not enough to this turn losing week into a winner
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: Wall Street higher, but likely not enough to this turn losing week into a winner
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
NASDAQ:LIVN

LivaNova (LIVN) Stock Forecast, Price & News

$55.79
-1.31 (-2.29%)
(As of 09/21/2023 ET)
Compare
Today's Range
$55.65
$56.82
50-Day Range
$52.14
$58.87
52-Week Range
$40.26
$59.86
Volume
240,848 shs
Average Volume
346,371 shs
Market Capitalization
$3.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$65.00

LivaNova MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
16.5% Upside
$65.00 Price Target
Short Interest
Bearish
3.73% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.97mentions of LivaNova in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
34.73%
From $2.39 to $3.22 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

670th out of 965 stocks

Electromedical Equipment Industry

16th out of 22 stocks


LIVN stock logo

About LivaNova (NASDAQ:LIVN) Stock

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. It also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

LIVN Price History

LIVN Stock News Headlines

LivaNova to Announce Third-Quarter 2023 Results
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Amgen and Biogen 'look attractive' - HSBC
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Stifel Nicolaus Sticks to Their Buy Rating for LivaNova (LIVN)
The Latest Analyst Ratings for LivaNova
LivaNova: Q2 Earnings Snapshot
LivaNova Reports Second-Quarter 2023 Results
Is LivaNova PLC (LIVN) a Good Value Stock?
See More Headlines
Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

LIVN Company Calendar

Last Earnings
7/26/2023
Today
9/22/2023
Next Earnings (Confirmed)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LIVN
Employees
2,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$65.00
High Stock Price Forecast
$84.00
Low Stock Price Forecast
$52.00
Forecasted Upside/Downside
+16.5%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Net Income
$-86,250,000.00
Pretax Margin
-7.80%

Debt

Sales & Book Value

Annual Sales
$1.02 billion
Cash Flow
$6.14 per share
Book Value
$22.56 per share

Miscellaneous

Free Float
53,781,000
Market Cap
$3.01 billion
Optionable
Optionable
Beta
0.89
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. William A. Kozy (Age 71)
    Chairman of Board & Interim CEO
    Comp: $185k
  • Mr. Alex Shvartsburg (Age 52)
    Chief Financial Officer
    Comp: $852.2k
  • Ms. Trui Hebbelinck (Age 51)
    Chief HR Officer
    Comp: $731.41k
  • Mr. Marco DolciMr. Marco Dolci (Age 61)
    Pres of Cardiopulmonary Bus. Unit
    Comp: $1.14M
  • Lindsey Little
    Sr. Director of Investor Relations
  • Mr. Michael Hutchinson (Age 52)
    Sr. VP, Chief Legal Officer & Company Sec.
  • Deanna Wilke
    VP of Corp. Communications
  • Mr. Matthew Joseph Dodds III
    Sr. VP of Corp. Devel. & IT
  • Dr. Bryan D. Olin Ph.D. (Age 56)
    Sr. VP & Head of Product Devel. - Neuromodulation
  • Mr. Ryan Miller
    Pres of Advanced Circulatory Support













LIVN Stock - Frequently Asked Questions

Should I buy or sell LivaNova stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" LIVN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LIVN, but not buy additional shares or sell existing shares.
View LIVN analyst ratings
or view top-rated stocks.

What is LivaNova's stock price forecast for 2023?

6 brokers have issued 12-month price objectives for LivaNova's stock. Their LIVN share price forecasts range from $52.00 to $84.00. On average, they anticipate the company's share price to reach $65.00 in the next twelve months. This suggests a possible upside of 16.5% from the stock's current price.
View analysts price targets for LIVN
or view top-rated stocks among Wall Street analysts.

How have LIVN shares performed in 2023?

LivaNova's stock was trading at $55.54 at the beginning of the year. Since then, LIVN shares have increased by 0.5% and is now trading at $55.79.
View the best growth stocks for 2023 here
.

When is LivaNova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our LIVN earnings forecast
.

How can I listen to LivaNova's earnings call?

LivaNova will be holding an earnings conference call on Wednesday, November 1st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were LivaNova's earnings last quarter?

LivaNova PLC (NASDAQ:LIVN) issued its quarterly earnings data on Wednesday, July, 26th. The company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.24. The business had revenue of $293.90 million for the quarter, compared to the consensus estimate of $265.05 million. LivaNova had a negative net margin of 8.94% and a positive trailing twelve-month return on equity of 11.60%. LivaNova's revenue for the quarter was up 15.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.53 EPS.

What guidance has LivaNova issued on next quarter's earnings?

LivaNova updated its FY23 earnings guidance on Wednesday, July, 26th. The company provided earnings per share (EPS) guidance of $2.55-$2.75 for the period, compared to the consensus earnings per share estimate of $2.59.

What is Damien McDonald's approval rating as LivaNova's CEO?

47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com. Damien McDonald has an approval rating of 77% among the company's employees.

What other stocks do shareholders of LivaNova own?
What is LivaNova's stock symbol?

LivaNova trades on the NASDAQ under the ticker symbol "LIVN."

Who are LivaNova's major shareholders?

LivaNova's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (13.51%), Alliancebernstein L.P. (4.13%), State Street Corp (3.69%), Hawk Ridge Capital Management LP (2.44%), Dimensional Fund Advisors LP (2.39%) and Geode Capital Management LLC (2.09%). Insiders that own company stock include Alfred J Novak, Damien Mcdonald, Daniel Jeffrey Moore and Marco Dolci.
View institutional ownership trends
.

How do I buy shares of LivaNova?

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LivaNova's stock price today?

One share of LIVN stock can currently be purchased for approximately $55.79.

How much money does LivaNova make?

LivaNova (NASDAQ:LIVN) has a market capitalization of $3.01 billion and generates $1.02 billion in revenue each year. The company earns $-86,250,000.00 in net income (profit) each year or ($1.82) on an earnings per share basis.

How many employees does LivaNova have?

The company employs 2,900 workers across the globe.

How can I contact LivaNova?

LivaNova's mailing address is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. The official website for the company is www.livanova.com. The company can be reached via phone at 442033250660, via email at investor.relations@livanova.com, or via fax at 281-218-9332.

This page (NASDAQ:LIVN) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -